JA1-TX

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameJA1-TX
Drug Alias NameJA1-TX (TxCell)JA1-TX
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsArthritis, Juvenile
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSangamo Therapeutics France Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSangamo Therapeutics France Sas
Active IndicationsN/A
Inactive IndicationsArthritis, Juvenile

Other Information

ATC CodeN/A
Related LinksN/A